Get the pharmacy’s actual identity

Ask for the legal name, address, and contact information of the pharmacy that will dispense your prescription. A statement that a service works with trusted partners is not enough to verify a specific location.

When the shipment arrives, compare that information with the label. If a different pharmacy supplied the product, ask why and confirm how to reach it. The organization answering billing questions may not be the one qualified to explain preparation, storage, or product concerns.

This distinction also helps when comparing services. A strong clinical consultation and a well-run pharmacy are separate parts of care. One does not automatically establish the quality of the other.

If the service will not name the pharmacy until after payment, ask what information is available before purchase and what happens if the proposed pharmacy cannot meet your needs. You can also ask whether the dispensing source may change between refills. Those questions make the commercial commitment clearer without treating any particular answer as proof of quality. The prescription label should ultimately identify the source of the product you receive.

Verify licensing through an independent source

FDA directs consumers to state pharmacy-board resources to check licensing. Search the actual name and location, and ask the board or pharmacy for help if the record is unclear.

A badge displayed on a commercial website is a claim to verify, not the verification itself. Likewise, a similarly named company in a database may be a different establishment. Matching the address helps avoid that mistake.

Licensing is an important credential, but it does not establish that a particular sermorelin formulation has proven benefit for sleep, weight loss, or anti-aging. Those claims require clinical evidence separate from the dispensing organization’s status.

Understand what 503A and 503B mean

FDA explains two statutory compounding frameworks. Section 503A addresses qualifying compounding by licensed pharmacists in state-licensed pharmacies or federal facilities, or by licensed physicians. Section 503B addresses registered outsourcing facilities and has a different set of requirements.

The distinction affects oversight and applicable conditions; it is not a simple two-level rating of how effective a medication will be. Ask which framework applies to the establishment preparing your product and how the answer relates to your prescription.

A facility’s registration with FDA is also not the same as FDA approval of every preparation it makes. Treat phrases such as FDA registered and FDA approved as different claims and ask the service to use them precisely.

Ask about the actual preparation

Confirm all active ingredients, the dosage form, the labeled strength, and the product-specific storage and beyond-use instructions. If you are offered a blend, ask why each ingredient is present and which clinician is responsible for that decision.

Ask how the pharmacy handles a damaged shipment, unclear labeling, a suspected quality problem, or a recall. Know whom to contact and which identifying information to retain. Keep the prescription label and lot information when available.

These questions do not require you to audit a manufacturing operation. They help establish whether the practical information needed for safe use is available and whether there is a clear route for resolving concerns about the product you receive.

Keep approval and efficacy separate from credentials

FDA states that compounded drugs are not FDA-approved. The agency does not review them for safety, effectiveness, and quality before marketing in the way it reviews approved drugs.

That distinction should remain clear even when the active ingredient has a historical approval or the pharmacy holds appropriate credentials. Our Geref and FDA-status guide explains the historical sermorelin issue.

A useful purchasing decision therefore has several parts: a sound clinical reason for treatment, evidence relevant to the intended benefit, a verified dispensing source, and understandable follow-up arrangements. No single badge or attractive price settles all four. For the wider process, read what an online prescription service should explain.

Sources & further reading

Sources reviewed October 2026. Provider prices and terms may change.

  1. FDA: verify a pharmacy through its state licensing board
  2. FDA: compounded drugs questions and answers
  3. FDA: statutory provisions for 503A and 503B compounding